NCT03474354View on ClinicalTrials.gov

DC Bead LUMI (TM) Loaded With Doxorubicin for Intermediate Hepatocellular Carcinoma (HCC)

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

May 2, 2018

Primary Completion Date

January 5, 2022

Study Completion Date

January 5, 2022

Conditions
Hepatocellular CancerChemoembolization
Interventions
DEVICE

chemoembolization

correlation of necrosis with the deposition of beads

Trial Locations (1)

15538

Evgenidion Hospital, Athens

All Listed Sponsors
lead

Malagari Katerina

OTHER

NCT03474354 - DC Bead LUMI (TM) Loaded With Doxorubicin for Intermediate Hepatocellular Carcinoma (HCC) | Biotech Hunter | Biotech Hunter